‘Lines in the sand’: an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders L Parker, Q Grundy, A Fabbri, B Mintzes, L Bero BMJ open 11 (2), e045140, 2021 | 6 | 2021 |
'Somebody Might Actually Make Up Data': An Empirical Qualitative Study on How to Screen for Fake Research L Parker, S Boughton, R Lawrence, L Bero Available at SSRN 4071671, 2022 | 2 | 2022 |
'Spin'in published biomedical literature: A methodological systematic review L Bero, K Chiu, Q Grundy Public Library of Science, 2017 | | 2017 |
‘Spin’in published biomedical literature: a methodological systematic review K Chiu, Q Grundy, L Bero PLoS Biology 15 (9), e2002173, 2017 | 242 | 2017 |
" Educational" advertisements--I haven't seen one yet! LA Bero The Western Journal of Medicine 174 (6), 395, 2001 | 1 | 2001 |
" It’s Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development N Chartres, Q Grundy, LM Parker, LA Bero International Journal of Health Policy and Management 9 (8), 335, 2020 | 3 | 2020 |
" The tobacco products research trust 1982-1996"-In Reply LA Bero TOBACCO CONTROL 7 (2), 193-193, 1998 | | 1998 |
“A delicate diplomatic situation”: tobacco industry efforts to gain control of the Framingham Study JK Cataldo, LA Bero, RE Malone Journal of clinical epidemiology 63 (8), 841-853, 2010 | 17 | 2010 |
“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study L Parker, A Fabbri, Q Grundy, B Mintzes, L Bero bmj 367, 2019 | 22 | 2019 |
“Developing good taste in evidence”: facilitators of and hindrances to evidence‐informed health policymaking in state government CJ Jewell, LA Bero The Milbank Quarterly 86 (2), 177-208, 2008 | 248 | 2008 |
“Experimental” institutional models for corporate funding of academic research: Unknown effects on the research enterprise L Bero Journal of clinical epidemiology 61 (7), 629-633, 2008 | 11 | 2008 |
“Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice K Chiu, AM Thow, L Bero Research in Social and Administrative Pharmacy 18 (9), 3638-3648, 2022 | 7 | 2022 |
“The lesser of two evils”: a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines AV Langford, D Gnjidic, CWC Lin, L Bero, F Blyth, J Penm, CR Schneider Pain 162 (11), 2686-2692, 2021 | 17 | 2021 |
“There are ways… drug companies will get into DTC decisions”: How Australian drug and therapeutics committees address pharmaceutical industry influence L Parker, A Bennett, B Mintzes, Q Grundy, A Fabbri, EA Karanges, L Bero British Journal of Clinical Pharmacology 87 (5), 2341-2353, 2021 | 8 | 2021 |
[O31] Reporting bias in clinical trials K Rising, K Lee, L Bero Cochrane Colloquium Abstracts Journal, 2007 | | 2007 |
[P121] Peer review and editorial decision-making at major biomedical journals K Lee, E Boyd, J Lightwood, L Bero Cochrane Colloquium Abstracts Journal, 2006 | | 2006 |
075 The Use of GRADE Methods in the World Health Organization (Who) Public Health Guidelines (PHG): Distribution of Strength of Recommendations and Confidence in Estimates of … P Elias, S Norris, J Brito, R Stoltzfus, L Bero, B Djulbegovic, I Neumann, ... BMJ Quality & Safety 22 (Suppl 1), A36-A36, 2013 | | 2013 |
19 Pharmaceutical industry payments to thought leaders in cardiovascular disease and diabetes E Karanges, N Ting, L Parker, A Fabbri, L Bero BMJ Evidence-Based Medicine 24 (Suppl 2), A16-A16, 2019 | | 2019 |
59 Perspectives of deprescribing experts on opioid overtreatment in australia: a focus group study C Schneider, A Langford, C Lin, J Penm, F Blyth, L Bero, D Gnjidic BMJ Evidence-Based Medicine 24 (Suppl 2), A35-A35, 2019 | | 2019 |
813 Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets better Maarten Boers 815 A delicate diplomatic situation Richard B. Campbell 818 The recession … DM Cook, A Stang, C Poole, R Bender, D Westreich, J Lessler, MJ Funk, ... | | |